Human Health and Potential (HHP)

Researchers pinpoint a specific marker for gastric cancer stem cells and show that eliminating this subpopulation may be a viable approach to more effectively treat stomach cancers.

In lung cancer, tumour-initiating cells harness ketones as an alternative energy source during nutrient stress, but this flexibility also leads to a therapeutic vulnerability.

Shattering a protein “shield” linked to drug resistance could offer clinicians a new weapon against advanced lung cancers.

A molecule found in Aedes mosquito saliva modulates the host body’s immune response during chikungunya infection, highlighting that mosquitoes may be more than just viral carriers.

A novel RNA-based molecular tool offers an innovative way to detect, amplify and respond to genetic signals within cells with unprecedented modularity.

A novel broad-spectrum drug candidate stalls replication of several SARS-CoV-2 variants and other coronaviruses, with the potential to boost preparedness against future pandemics.

Soft textures, fibrous structures and improved protein digestibility—plant-based meat products could have these all, when processed using the right concentration and type of enzyme.

Researchers identify a molecular driver of cell death in a rare neurodegenerative disease and show how targeted oligonucleotide therapies can combat the process.

A*STAR researchers uncover how bacterial hideouts created during tuberculosis infections can also protect and feed other opportunistic invaders.

A*STAR researchers have developed a microneedle patch technology that can deliver drugs and vaccines more effectively and with minimal invasiveness.

A new cellular model of colorectal cancer helps identify high-risk subtypes likely to resist standard treatments and proliferate in response.

By examining how soy protein concentrates affect protein fibrous texture, scientists address existing quality control issues faced by meat-alternative manufacturers.